| Official American thoracic society/centers for disease control and prevention/infectious diseases society of America clinical practice guidelines: treatment of drug-susceptible … P Nahid, SE Dorman, N Alipanah, PM Barry, JL Brozek, A Cattamanchi, ... Clinical infectious diseases 63 (7), e147-e195, 2016 | 1512 | 2016 |
| Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS M Narita, D Ashkin, ES Hollender, AE Pitchenik American journal of respiratory and critical care medicine 158 (1), 157-161, 1998 | 847 | 1998 |
| Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis DJ Horne, SE Royce, L Gooze, M Narita, PC Hopewell, P Nahid, ... The Lancet infectious diseases 10 (6), 387-394, 2010 | 312 | 2010 |
| Revisiting rates of reactivation tuberculosis: a population-based approach CR Horsburgh Jr, M O'Donnell, S Chamblee, JL Moreland, J Johnson, ... American journal of respiratory and critical care medicine 182 (3), 420-425, 2010 | 184 | 2010 |
| Pulmonary tuberculosis in AIDS patients: transient chest radiographic worsening after initiation of antiretroviral thrapy JE Fishman, E Saraf-Lavi, M Narita, ES Hollender, R Ramsinghani, ... American Journal of Roentgenology 174 (1), 43-49, 2000 | 164 | 2000 |
| Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first-and second-line drugs: an … ML Bastos, H Hussain, K Weyer, L Garcia-Garcia, V Leimane, CC Leung, ... Clinical infectious diseases 59 (10), 1364-1374, 2014 | 158 | 2014 |
| Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium SE Dorman, S Goldberg, JE Stout, G Muzanyi, JL Johnson, M Weiner, ... The Journal of infectious diseases 206 (7), 1030-1040, 2012 | 138 | 2012 |
| Use of rifabutin with protease inhibitors for human immunodeficiency virus-infected patients with tuberculosis M Narita, JJ Stambaugh, ES Hollender, D Jones, AE Pitchenik, D Ashkin Clinical infectious diseases 30 (5), 779-783, 2000 | 117 | 2000 |
| Treatment experience of multidrug-resistant tuberculosis in Florida, 1994–1997 M Narita, P Alonso, M Lauzardo, ES Hollender, AE Pitchenik, D Ashkin Chest 120 (2), 343-348, 2001 | 105 | 2001 |
| Factors associated with mortality in patients with tuberculosis DJ Horne, R Hubbard, M Narita, A Exarchos, DR Park, CH Goss BMC Infectious Diseases 10, 1-8, 2010 | 92 | 2010 |
| Tuberculosis outbreak in marijuana users, Seattle, Washington, 2004 JE Oeltmann, E Oren, MB Haddad, LK Lake, TA Harrington, K Ijaz, ... Emerging infectious diseases 12 (7), 1156, 2006 | 89 | 2006 |
| Challenging issues in tuberculosis in solid organ transplantation DJ Horne, M Narita, CL Spitters, S Parimi, S Dodson, AP Limaye Clinical infectious diseases 57 (10), 1473-1482, 2013 | 83 | 2013 |
| Blockade of late-phase airway responses and airway hyperresponsiveness in allergic sheep with a small-molecule peptide inhibitor of VLA-4 WM Abraham, A Ahmed, MW Sielczak, M Narita, T Arrhenius, MJ Elices American journal of respiratory and critical care medicine 156 (3), 696-703, 1997 | 80 | 1997 |
| Tuberculosis recurrence: multivariate analysis of serum levels of tuberculosis drugs, human immunodeficiency virus status, and other risk factors M Narita, M Hisada, B Thimmappa, JJ Stambaugh, E Ibrahim, ... Clinical infectious diseases 32 (3), 515-517, 2001 | 74 | 2001 |
| Association between smoking and latent tuberculosis in the US population: an analysis of the National Health and Nutrition Examination Survey DJ Horne, M Campo, JR Ortiz, E Oren, M Arentz, K Crothers, M Narita PloS one 7 (11), e49050, 2012 | 73 | 2012 |
| Experience with rifabutin replacing rifampin in the treatment of tuberculosis DJ Horne, C Spitters, M Narita The International journal of tuberculosis and lung disease 15 (11), 1485-1490, 2011 | 69 | 2011 |
| Exposure to latent tuberculosis treatment during pregnancy. The PREVENT TB and the iAdhere trials RN Moro, NA Scott, A Vernon, NK Tepper, SV Goldberg, K Schwartzman, ... Annals of the American Thoracic Society 15 (5), 570-580, 2018 | 61 | 2018 |
| Unexpected pulmonary involvement in extrapulmonary tuberculosis patients T Parimon, CE Spitters, N Muangman, J Euathrongchit, E Oren, M Narita Chest 134 (3), 589-594, 2008 | 61 | 2008 |
| Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine AH McClintock, MK Eastment, CM McKinney, CL Pitney, M Narita, ... BMC infectious diseases 17, 1-8, 2017 | 51 | 2017 |
| Human ULK1 Variation and Susceptibility to Mycobacterium tuberculosis Infection DJ Horne, AD Graustein, JA Shah, G Peterson, M Savlov, S Steele, ... The Journal of infectious diseases 214 (8), 1260-1267, 2016 | 45 | 2016 |
